{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:09:29Z","timestamp":1778674169252,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100015083","name":"Peking University People's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["KF-202305"],"award-info":[{"award-number":["KF-202305"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["RZ2022-06"],"award-info":[{"award-number":["RZ2022-06"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271755"],"award-info":[{"award-number":["82271755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871230"],"award-info":[{"award-number":["81871230"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.imlet.2025.107054","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T02:32:07Z","timestamp":1750386727000},"page":"107054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reduced CD37 expression in B cell subsets after stimulation and its clinical relevance in primary Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"276","author":[{"given":"Zhonghui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanxi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7120-5626","authenticated-orcid":false,"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.imlet.2025.107054_bib0001","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren's Syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.imlet.2025.107054_bib0002","first-page":"2211","article-title":"Sj\u00f6gren's syndrome: one year in review 2022","volume":"40","author":"Manfr\u00e8","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.imlet.2025.107054_bib0003","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","article-title":"B-cell hyperactivity in primary Sj\u00f6gren's syndrome","volume":"10","author":"Kroese","year":"2014","journal-title":"Exp. Rev. Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107054_bib0004","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clim.2017.10.008","article-title":"Increased proportion of a CD38(high)IgD(+) B cell subset in peripheral blood is associated with clinical and immunological features in patients with primary Sj\u00f6gren's syndrome","volume":"187","author":"Ishioka-Takei","year":"2018","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2025.107054_bib0005","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/art.42422","article-title":"Association of Circulating Antibody-Secreting Cell Maturity With Disease Features in Primary Sj\u00f6gren's Syndrome","volume":"75","author":"Steinmetz","year":"2023","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107054_bib0006","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/clim.2002.5199","article-title":"Abnormal B cell differentiation in primary Sj\u00f6gren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration","volume":"103","author":"Bohnhorst","year":"2002","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107054_bib0007","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107054_bib0008","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/ar4571","article-title":"B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sj\u00f6gren's syndrome: the similarities and differences","volume":"16","author":"Lin","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.imlet.2025.107054_bib0009","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41423-019-0227-z","article-title":"IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sj\u00f6gren's syndrome","volume":"16","author":"Lin","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107054_bib0010","doi-asserted-by":"crossref","first-page":"905","DOI":"10.4049\/jimmunol.140.3.905","article-title":"The B cell-associated CD37 antigen (gp40-52). Structure and subcellular expression of an extensively glycosylated glycoprotein","volume":"140","author":"Schwartz-Albiez","year":"1988","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2025.107054_bib0011","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrm1736","article-title":"Tetraspanin functions and associated microdomains","volume":"6","author":"Hemler","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.imlet.2025.107054_bib0012","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF00188787","article-title":"Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2\/C33) with MHC class II glycoproteins","volume":"39","author":"Angelisov\u00e1","year":"1994","journal-title":"Immunogenetics"},{"issue":"15","key":"10.1016\/j.imlet.2025.107054_bib0013","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/MCB.20.15.5363-5369.2000","article-title":"Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions","volume":"20","author":"Knobeloch","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.imlet.2025.107054_bib0014","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3389\/fimmu.2018.01644","article-title":"The Many and Varied Roles of Tetraspanins in Immune Cell Recruitment and Migration","volume":"9","author":"Yeung","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2025.107054_bib0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ccr.2012.03.040","article-title":"Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals","volume":"21","author":"Lapalombella","year":"2012","journal-title":"Cancer Cell."},{"issue":"250","key":"10.1016\/j.imlet.2025.107054_bib0016","doi-asserted-by":"crossref","first-page":"ra82","DOI":"10.1126\/scisignal.2003113","article-title":"The tetraspanin CD37 orchestrates the \u03b1(4)\u03b2(1) integrin-Akt signaling axis and supports long-lived plasma cell survival","volume":"5","author":"van Spriel","year":"2012","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.imlet.2025.107054_bib0017","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2362454","article-title":"CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies","volume":"13","author":"Bobrowicz","year":"2024","journal-title":"Oncoimmunology"},{"issue":"26","key":"10.1016\/j.imlet.2025.107054_bib0018","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1182\/blood-2016-05-715094","article-title":"Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma","volume":"128","author":"Xu-Monette","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imlet.2025.107054_bib0019","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40364-021-00309-5","article-title":"Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma","volume":"9","author":"Yin","year":"2021","journal-title":"Biomark. Res."},{"issue":"14","key":"10.1016\/j.imlet.2025.107054_bib0020","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2018-04-842708","article-title":"Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas","volume":"132","author":"Scarf\u00f2","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.imlet.2025.107054_bib0021","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1172\/JCI81041","article-title":"Tetraspanin CD37 protects against the development of B cell lymphoma","volume":"126","author":"de Winde","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.imlet.2025.107054_bib0022","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1038\/s41467-022-33138-7","article-title":"Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37","volume":"13","author":"Peeters","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.imlet.2025.107054_bib0023","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.2353\/ajpath.2010.090770","article-title":"The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology","volume":"176","author":"Rops","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.imlet.2025.107054_bib0024","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.kint.2018.01.005","article-title":"Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice","volume":"93","author":"Rops","year":"2018","journal-title":"Kidney. Int."},{"issue":"4","key":"10.1016\/j.imlet.2025.107054_bib0025","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaci.2022.10.034","article-title":"Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa","volume":"151","author":"Sabat","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107054_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02458","article-title":"Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations","volume":"10","author":"Sanz","year":"2019","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2025.107054_bib0027","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.imlet.2025.107054_bib0028","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/1744666X.2018.1485492","article-title":"CD40 as a therapeutic target in Sj\u00f6gren's syndrome","volume":"14","author":"Jobling","year":"2018","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107054_bib0029","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.humimm.2018.04.013","article-title":"B cell MHC class II signaling: a story of life and death","volume":"80","author":"Katikaneni","year":"2019","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107054_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000338","article-title":"The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity","volume":"5","author":"van Spriel","year":"2009","journal-title":"PLoS. Pathog."},{"issue":"8","key":"10.1016\/j.imlet.2025.107054_bib0031","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/sj.leu.2403822","article-title":"Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation","volume":"19","author":"Barrena","year":"2005","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.imlet.2025.107054_bib0032","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0165-2478(99)00068-1","article-title":"Bacterial lipopolysaccharide induced B cell activation is mediated via a phosphatidylinositol 3-kinase dependent signaling pathway","volume":"69","author":"Venkataraman","year":"1999","journal-title":"Immunol. Lett."},{"issue":"1\u20132","key":"10.1016\/j.imlet.2025.107054_bib0033","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2012.01.016","article-title":"Role of Toll-like receptors in primary Sj\u00f6gren's syndrome with a special emphasis on B-cell maturation within exocrine tissues","volume":"39","author":"Guerrier","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2025.107054_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840751","article-title":"Trained Immunity in Primary Sj\u00f6gren's Syndrome: linking Type I Interferons to a Pro-Atherogenic Phenotype","volume":"13","author":"Huijser","year":"2022","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2025.107054_bib0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-3083.2007.02049.x","article-title":"B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sj\u00f6gren's syndrome","volume":"67","author":"Lavie","year":"2008","journal-title":"Scand J. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2025.107054_bib0036","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1038\/s41401-024-01288-7","article-title":"Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sj\u00f6gren's syndrome in mice by promoting TEC kinase degradation","volume":"45","author":"Yang","year":"2024","journal-title":"Acta Pharmacol. Sin"},{"issue":"1","key":"10.1016\/j.imlet.2025.107054_bib0037","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/07853890.2022.2031272","article-title":"Comparison of the deep immune profiling of B cell subsets between healthy adults and Sj\u00f6gren's syndrome","volume":"54","author":"Feng","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.imlet.2025.107054_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112262","article-title":"Emerging roles of suppressor of cytokine signaling 3 in human cancers","volume":"144","author":"Dai","year":"2021","journal-title":"Biomed Pharmacother."},{"issue":"2","key":"10.1016\/j.imlet.2025.107054_bib0039","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0165-2478(99)00068-1","article-title":"Bacterial lipopolysaccharide induced B cell activation is mediated via a phosphatidylinositol 3-kinase dependent signaling pathway","volume":"69","author":"Venkataraman","year":"1999","journal-title":"Immunol. Lett."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:15:12Z","timestamp":1778670912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"alternative-id":["S0165247825000872"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107054","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced CD37 expression in B cell subsets after stimulation and its clinical relevance in primary Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107054"}}